News

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent Medicare coverage of the OncoPrism ...
However, he said that the game's next expansion wouldn't be on that roadmap. It's not coming until 2026. "In 2025, or just before Season 8, we will have a 2025 roadmap for Diablo 4.
The next major expansion for Diablo IV won’t come out until 2026, according to remarks made by franchise general manager Rod Fergusson at the DICE Summit in Las Vegas on Wednesday.
At the DICE video game networking conference, Rod Fergusson, General Manager of Diablo 4, announced that the game's next expansion, set to follow Vessel of Hatred, will launch in 2026. This news ...
If you've yet to jump into the latest Diablo 4 expansion, we have a Vessel of Hatred review right here (we enjoyed it). If you can't wait to further your D4 story then check out the new Diablo 4 ...
Diablo 4 Season 6 is starting today (October 7 PDT), but more importantly, its first-ever expansion, Vessel of Hatred, will also be released.
Diablo IV’s first big expansion, Vessel of Hatred, is just a few weeks away.The add-on will bring new stories, quests, and the Spiritborn class on October 8. If you’ve been sleeping on it ...
To my intense joy, Vessel of Hatred is very much a Blizzard expansion pack in that classic mould, continuing the cliff-hanger ending of Diablo 4, adding on a wickedly fun new character class and ...
Vessel of Hatred is the game’s first major piece of new content since its release last year, and Blizzard is inviting players to see what Diablo 4 is all about ahead of the expansion’s release.
Platform Now Covering Majority of Patients with Solid-tumor Cancers Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent ...
ST. LOUIS, March 05, 2025--Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent Medicare coverage of the OncoPrism ...